Related Experiment Videos
EUS changes diagnosis from pancreatic to gallbladder carcinoma
Jesse Lachter1, Shirley Zelikovsky
1Western Galilee Medical Center, Nahariya, Israel. ramila@netvision.net.il
International Journal of Gastrointestinal Cancer
|June 10, 2003
Summary
Endoscopic ultrasound (EUS) revealed gallbladder cancer, not pancreatic cancer, in a patient with elevated CA19-9. This highlights EUS's role in diagnosing unexpected conditions and guiding curative treatment.
Area of Science:
- Gastroenterology
- Oncology
- Diagnostic Imaging
Background:
- Preoperative staging for suspected pancreatic cancer often involves imaging like CT and tumor markers such as CA19-9.
- Elevated CA19-9 and subtle CT findings can suggest pancreatic malignancy, necessitating accurate diagnostic evaluation.
Observation:
- A patient presented with clinical indicators suggestive of pancreatic cancer.
- Endoscopic ultrasound (EUS) demonstrated a normal pancreas but identified a tumor mass in the gallbladder.
- EUS-guided fine-needle aspiration (FNA) confirmed the gallbladder mass as adenocarcinoma.
Findings:
- The patient was initially suspected of having pancreatic cancer based on elevated CA19-9 and CT findings.
- EUS accurately identified the primary tumor in the gallbladder, not the pancreas.
- Surgical resection (cholecystectomy) proved curative for the gallbladder adenocarcinoma.
Implications:
- CA19-9 is not a highly specific tumor marker and can be elevated in various conditions.
- Endoscopic ultrasound is a sensitive and specific tool for diagnosing pancreatic and other gastrointestinal pathologies.
- EUS can uncover unexpected diagnoses, complementing other imaging modalities and significantly impacting patient management and treatment outcomes.